Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bavarian Nordic, Foghorn, Hepagene, Kezar, Lexicon, Orphazyme Plus, Puretech, Sen-Jam.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Fate.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Coherus, Compugen, Intrabio, Janssen, Junshi, Nervgen, Nrx, Scioto, Zealand, Zhaoke.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aptevo, Azurrx, Cabaletta, Cidara, Cinclus, Citryll, Exevir, Galecto, Geron, Innovent, Istari, Kintara, Kyowa Kirin, Marinus, Mei, Receptor, Telix, Tiziana, Transcenta.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amerimmune, Axcella, Biophytis, Biosight, Brickell, Eli Lilly, Enanta, Innocare, Innovent, Moderna, Oramed, Praxis, Sagimet, Senhwa, Tikomed, Travere, Turning Point.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Atea, Azurrx, Cali, Equillium, Gigagen, Innovent, Innovation, Longeveron, Lynk, Medivir, Phasebio, Trigone, Ultimovacs, Valneva.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apollomics, Athersys, Avacta, Azurrx, Cohbar, Crinetics, Cytoagents, Flexion, Fulcrum, Goldfinch, Grunenthal, Healios, Heparegenix, I-Mab, Immvira, IMV, In8bio, Inflarx, Novaliq, Nrx, Point, Pulmatrix, Reata, Retrotope, Rezolute, Sinovac, Summit, Trevena.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Aravive, Axsome, Bavarian Nordic, Biontech, Daiichi Sankyo, Impel, Opthea, Pfizer, Roche, Synedgen, Tracon, Trillium, UCB.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akeso, Athersys, Dicerna, Healios, Innovent, Neurocrine.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Biovie, Clene, Exicure, Imara, Merck, Monopar, Noema, Portage, RDIF, Regeneron, Sanofi, Stemedica, Takeda, Telix, Ultimovacs.